Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Nelfinavir × 90 days × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1

Interventions

Bevacizumab 5 pembrolizumab 4 Radiotherapy 4 Capecitabine 4 anlotinib 3 Radiosurgery 3 tislelizumab 2 durvalumab 2 atezolizumab 2 Oxaliplatin 2 Olanzapine 2 Hyperthermic Intraperitoneal Chemotherapy 2 Dexamethasone 2 Cisplatin 2 trilaciclib 1 trastuzumab deruxtecan 1 spartalizumab 1 pyrotinib 1 pomalidomide 1 pegfilgrastim 1 olaparib 1 lenvatinib 1 ledipasvir, sofosbuvir drug combination 1 ledipasvir 1 hetrombopag 1 fosaprepitant 1 ferric maltol 1 defactinib 1 decitabine and cedazuridine drug combination 1 dalpiciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03256916 2026-02-24

NELCER

Tata Memorial Hospital

Phase 3 Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡